TORONTO, June 6 /CNW/ - ARIUS Research Inc., (TSX: ARI), a biotechnology
company discovering and developing the next wave of antibody therapeutics,
today announced the appointment of Robert Gundel, Ph.D., MBA, to the position
of Chief Scientific Officer.
